Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Optimizing Management of Treatment-Resistant Schizophrenia in Japan: Promoting a Refined Clozapine Titration Protocol and Addressing the ‘Clozapine Ceiling’ through Glutamatergic Modulation

AI Summary
  • Refine clozapine titration protocols in Japan to enhance safety, tolerability and therapeutic response for treatment resistant schizophrenia.
  • Explore glutamatergic modulation as an adjunctive strategy to overcome the clozapine ceiling and address persistent symptoms.
  • Implement integrated clinical and policy measures combining titration refinement and glutamatergic approaches to optimise national TRS management.
Summarise with AI (MRCPsych/FRANZCP)

Psychiatry Clin Neurosci. 2026 Jun 12. doi: 10.1111/pcn.70093. Online ahead of print.

NO ABSTRACT

PMID:42283138 | DOI:10.1111/pcn.70093

Document this CPD

AI Search

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review